NCT04344977View on ClinicalTrials.gov

Collection of Anti-SARS-CoV-2 Immune Plasma

CompletedOBSERVATIONAL
Enrollment

151

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

November 20, 2020

Study Completion Date

March 3, 2021

Conditions
Coronavirus Disease 2019 (COVID-19)
Trial Locations (3)

33136

University of Miami Infectious Diseases Research Unit, Miami

90502

Lundquist Institute for Biomedical Innovation at Harbor - UCLA Medical Center, Torrance

98104

Bloodworks Northwest, Seattle

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT04344977 - Collection of Anti-SARS-CoV-2 Immune Plasma | Biotech Hunter | Biotech Hunter